Payment overview · 2025
General Payments
$93.07
6 reported records · 4 companies
Healthcare provider profile · identity verified
Daniel C Souphis, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · FORT GRATIOT, MI · NPI 1225004252
Verified facts
What the public records show
CMS Open Payments records show Daniel C Souphis, D.O. received $93.07 in general payments during 2025 across 6 reported records.
GlaxoSmithKline, LLC. accounted for 33.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Synthroid by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENBREL as an associated drug or biological on 9330 records involving 2094 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Enbrel by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $30.67 | 33.0% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $28.69 | 30.8% | 2 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $19.22 | 20.6% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $14.49 | 15.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $93.07 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $28.69 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $28.69 | 2 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $19.22 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $17.03 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $14.49 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $13.64 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $13.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 53 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
50 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | ENBREL open payments reported associated product |
CMS Open Payments — General Payments 9330 supporting records · 2094 recipient NPIs · example record 1226877474 |
Enbrel · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
53 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1560 | 355 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1065 | 218 |
| Amlodipine Besylate | Amlodipine Besylate | 859 | 200 |
| Metoprolol Tartrate | Metoprolol Tartrate | 776 | 147 |
| Lisinopril | Lisinopril | 772 | 206 |
| Eliquis | Apixaban | 608 | 101 |
| Furosemide | Furosemide | 577 | 118 |
| Metformin Hcl | Metformin Hcl | 518 | 114 |
| Potassium Chloride | Potassium Chloride | 510 | 88 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 486 | 96 |
| Gabapentin | Gabapentin | 470 | 99 |
| Losartan Potassium | Losartan Potassium | 456 | 113 |
| Tamsulosin Hcl | Tamsulosin Hcl | 437 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 431 | 114 |
| Omeprazole | Omeprazole | 415 | 128 |
| Sertraline Hcl | Sertraline Hcl | 387 | 75 |
| Simvastatin | Simvastatin | 335 | 78 |
| Alprazolam | Alprazolam | 329 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 300 | 80 |
| Famotidine | Famotidine | 289 | 78 |
| Escitalopram Oxalate | Escitalopram Oxalate | 264 | 58 |
| Duloxetine Hcl | Duloxetine Hcl | 240 | 47 |
| Mounjaro | Tirzepatide | 237 | 41 |
| Jardiance | Empagliflozin | 214 | 33 |
| Trazodone Hcl | Trazodone Hcl | 209 | 41 |
| Montelukast Sodium | Montelukast Sodium | 205 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 204 | 53 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 204 | 57 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 197 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 189 | 66 |
| Metformin Hcl Er | Metformin Hcl | 171 | 51 |
| Trulicity | Dulaglutide | 170 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 169 | 43 |
| Spironolactone | Spironolactone | 169 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 165 | 34 |
| Enulose | Lactulose | 161 | 13 |
| Tramadol Hcl | Tramadol Hcl | 160 | 38 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 149 | 32 |
| Carvedilol | Carvedilol | 143 | 35 |
| Farxiga | Dapagliflozin Propanediol | 138 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 136 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 133 | 30 |
| Donepezil Hcl | Donepezil Hcl | 131 | 25 |
| Atenolol | Atenolol | 130 | 33 |
| Lorazepam | Lorazepam | 128 | 43 |
| Levetiracetam | Levetiracetam | 124 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 122 | 17 |
| Olanzapine | Olanzapine | 119 | suppressed |
| Xarelto | Rivaroxaban | 119 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 115 | 38 |
| Nystatin | Nystatin | 112 | 35 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 112 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 112 | 19 |
| Allopurinol | Allopurinol | 110 | 33 |
| Baclofen | Baclofen | 109 | 25 |
| Budesonide | Budesonide | 108 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 38 |
| Meloxicam | Meloxicam | 108 | 30 |
| Buspirone Hcl | Buspirone Hcl | 106 | 20 |
| Memantine Hcl | Memantine Hcl | 101 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 101 | 42 |
| Latanoprost | Latanoprost | 100 | 15 |
| Lovastatin | Lovastatin | 99 | 27 |
| Clonazepam | Clonazepam | 98 | 14 |
| Januvia | Sitagliptin Phosphate | 91 | 16 |
| Topiramate | Topiramate | 90 | 15 |
| Lamotrigine | Lamotrigine | 88 | 13 |
| Mirtazapine | Mirtazapine | 87 | 21 |
| Glipizide Er | Glipizide | 83 | 22 |
| Finasteride | Finasteride | 81 | 16 |
| Methylprednisolone | Methylprednisolone | 81 | 58 |
| Cefuroxime | Cefuroxime Axetil | 79 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 79 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 78 | 35 |
| Novolog | Insulin Aspart | 77 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 75 | 20 |
| Prednisone | Prednisone | 75 | 26 |
| Risperidone | Risperidone | 74 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 73 | 16 |
| Chlorthalidone | Chlorthalidone | 71 | 22 |
| Divalproex Sodium | Divalproex Sodium | 70 | 13 |
| Primidone | Primidone | 70 | 11 |
| Eszopiclone | Eszopiclone | 69 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 69 | 19 |
| Myrbetriq | Mirabegron | 69 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 68 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 68 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | 19 |
| Glipizide | Glipizide | 66 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 66 | 23 |
| Amiodarone Hcl | Amiodarone Hcl | 65 | 17 |
| Ibuprofen | Ibuprofen | 64 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 59 | 15 |
| Bupropion Xl | Bupropion Hcl | 58 | 11 |
| Novolog Flexpen | Insulin Aspart | 56 | 22 |
| Tradjenta | Linagliptin | 55 | suppressed |
| Cephalexin | Cephalexin | 54 | 31 |
| Ezetimibe | Ezetimibe | 54 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 53 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 53 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 24 |
| Meclizine Hcl | Meclizine Hcl | 52 | 30 |
| Aripiprazole | Aripiprazole | 51 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 51 | 32 |
| Alendronate Sodium | Alendronate Sodium | 50 | suppressed |
| Armour Thyroid | Thyroid,pork | 50 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 50 | 37 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 50 | 29 |
| Pregabalin | Pregabalin | 46 | suppressed |
| Valsartan | Valsartan | 46 | 12 |
| Warfarin Sodium | Warfarin Sodium | 46 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 44 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | 12 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 44 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 41 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | suppressed |
| Azithromycin | Azithromycin | 40 | 35 |
| Carbamazepine Er | Carbamazepine | 40 | suppressed |
| Protonix | Pantoprazole Sodium | 40 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 40 | 11 |
| Clozapine | Clozapine | 39 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Bumetanide | Bumetanide | 36 | 11 |
| Clonidine | Clonidine | 36 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 36 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | 11 |
| Ozempic | Semaglutide | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 33 | suppressed |
| Glimepiride | Glimepiride | 33 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 33 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 32 | 25 |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 32 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | 12 |
| Methenamine Hippurate | Methenamine Hippurate | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | 18 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 29 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 20 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 28 | suppressed |
| Hydrocortisone | Hydrocortisone | 28 | 11 |
| Levalbuterol Hcl | Levalbuterol Hcl | 28 | suppressed |
| Mupirocin | Mupirocin | 28 | 16 |
| Valacyclovir | Valacyclovir Hcl | 28 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 25 |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | suppressed |
| Diazepam | Diazepam | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 25 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 25 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 24 | suppressed |
| Cilostazol | Cilostazol | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Folic Acid | Folic Acid | 24 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | 12 |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 23 | suppressed |
| Ciclopirox | Ciclopirox | 22 | 12 |
| Clindamycin Hcl | Clindamycin Hcl | 22 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 22 | 13 |
| Metronidazole | Metronidazole | 22 | 12 |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | 15 |
| Celecoxib | Celecoxib | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Enbrel | Etanercept | 20 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 20 | 14 |
| Amoxicillin | Amoxicillin | 19 | 15 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 14 |
| Nystop | Nystatin | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Repaglinide | Repaglinide | 19 | suppressed |
| Restasis | Cyclosporine | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 18 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Azathioprine | Azathioprine | 17 | suppressed |
| Cartia Xt | Diltiazem Hcl | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Paliperidone Er | Paliperidone | 17 | suppressed |
| Rexulti | Brexpiprazole | 17 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Xtandi | Enzalutamide | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 11 |
| Linzess | Linaclotide | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 14 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Bicalutamide | Bicalutamide | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Forteo | Teriparatide | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $93.07 · 6 records | GlaxoSmithKline, LLC. | AREXVY, NUPLAZID, OTEZLA, REPATHA, SHINGRIX, TRELEGY ELLIPTA, VRAYLAR | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error